Introdução
Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Randal J Kirk. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.
Rentabilidade Média de Negociação
A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.
Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.
Frequência de Atualização: Diariamente
Empresas com Posições Internas Reportadas
As declarações à SEC indicam que Randal J Kirk reportou posses ou negociações nas seguintes empresas:
| Ativo | Título | Últimas Posições Reportadas |
|---|---|---|
| US:PGEN / Precigen, Inc. | Director, 10% Owner | 12,262,741 |
| US:AQB / AquaBounty Technologies, Inc. | 10% Owner | 3,747 |
| US:FCSC / Fibrocell Science Inc. | 10% Owner | 0 |
| US:SYN / Synthetic Biologics Inc | 10% Owner | 165,332 |
| US:HSGX / Histogenics Corporation | 10% Owner | 1,692,366 |
| US:ZIOP / Alaunos Therapeutics Inc | Director | 0 |
| US:PRPO / Precipio, Inc. | 10% Owner | 27,151 |
| US:HALO / Halozyme Therapeutics, Inc. | 10% Owner | 1,897,610 |
| US:SNGX / Soligenix, Inc. | 10% Owner | 85,397 |
| US:APHB / Ampliphi Biosciences Corp. | 10% Owner | 674,169 |
| US:OGEN / Oragenics, Inc. | 10% Owner | 14,481,089 |
Como Interpretar os Gráficos
Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Randal J Kirk. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.
Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.
No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.
O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.
Compras Internas AQB / AquaBounty Technologies, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas AQB / AquaBounty Technologies, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas ARMP / Armata Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Máx |
Preço em Máx |
Lucro Máx ($) |
Retorno Máx (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-16 | APHB | KIRK RANDAL J | 13,939,392 | 0.1650 | 13,939,392 | 0.1650 | 2,300,000 | 144 |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas ARMP / Armata Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas HALO / Halozyme Therapeutics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas HALO / Halozyme Therapeutics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas OCGN / Ocugen, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Máx |
Preço em Máx |
Lucro Máx ($) |
Retorno Máx (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas OCGN / Ocugen, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas OGEN / Oragenics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas OGEN / Oragenics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas PGEN / Precigen, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas PGEN / Precigen, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas PRPO / Precipio, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas PRPO / Precipio, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas SNGX / Soligenix, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Máx |
Preço em Máx |
Lucro Máx ($) |
Retorno Máx (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas SNGX / Soligenix, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas TCRT / Alaunos Therapeutics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas TCRT / Alaunos Therapeutics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas TOVX / Theriva Biologics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AQB / AquaBounty Technologies, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas TOVX / Theriva Biologics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AQB / AquaBounty Technologies, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Histórico de Negociações Insider
Esta tabela mostra a lista completa de negociações insider realizadas por Randal J Kirk conforme divulgadas para a Comissão de Valores Mobiliários (SEC).
| Data do Arquivo | Data da Transação | Formulário | Ticker | Ativo | Código | Ações | Ações Restantes | Variação Percentual |
Preço da Ação |
Valor da Transação |
Valor Restante |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -2,334,420 | 12,262,741 | -15.99 | 3.30 | -7,703,586 | 40,467,045 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -23,789 | 423,984 | -5.31 | 3.30 | -78,504 | 1,399,147 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -38,976 | 302,213 | -11.42 | 3.30 | -128,621 | 997,303 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -47,101 | 519,061 | -8.32 | 3.30 | -155,433 | 1,712,901 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -168,794 | 1,425,544 | -10.59 | 3.30 | -557,020 | 4,704,295 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -426,199 | 3,358,917 | -11.26 | 3.30 | -1,406,457 | 11,084,426 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -50,797 | 425,732 | -10.66 | 3.30 | -167,630 | 1,404,916 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -152,063 | 1,463,571 | -9.41 | 3.30 | -501,808 | 4,829,784 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -370,847 | 3,238,210 | -10.28 | 3.30 | -1,223,795 | 10,686,093 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -50,797 | 426,695 | -10.64 | 3.30 | -167,630 | 1,408,094 | |
| 2026-03-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -1,108,998 | 80,672,818 | -1.36 | 3.30 | -3,659,693 | 266,220,299 | |
| 2026-03-16 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 143,678 | 81,781,816 | 0.18 | ||||
| 2026-03-12 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 28,490 | 81,638,138 | 0.03 | 3.51 | 100,000 | 286,549,864 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -956,200 | 4,598,044 | -17.22 | 4.18 | -3,996,916 | 19,219,824 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -5,958 | 447,773 | -1.31 | 4.18 | -24,904 | 1,871,691 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -9,931 | 341,189 | -2.83 | 4.18 | -41,512 | 1,426,170 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -11,917 | 566,162 | -2.06 | 4.18 | -49,813 | 2,366,557 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -42,702 | 1,594,338 | -2.61 | 4.18 | -178,494 | 6,664,333 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -159,321 | 3,785,116 | -4.04 | 4.18 | -665,962 | 15,821,785 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -12,909 | 476,529 | -2.64 | 4.18 | -53,960 | 1,991,891 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -38,729 | 1,615,634 | -2.34 | 4.18 | -161,887 | 6,753,350 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -94,341 | 3,609,057 | -2.55 | 4.18 | -394,345 | 15,085,858 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -12,909 | 477,492 | -2.63 | 4.18 | -53,960 | 1,995,917 | |
| 2025-12-22 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -555,119 | 81,609,648 | -0.68 | 4.18 | -2,320,397 | 341,128,329 | |
| 2025-11-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -937,308 | 5,554,244 | -14.44 | 3.83 | -3,589,890 | 21,272,755 | |
| 2025-11-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -942,832 | 6,491,552 | -12.68 | 4.08 | -3,846,755 | 26,485,532 | |
| 2025-11-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -1,086,153 | 7,434,384 | -12.75 | 4.47 | -4,855,104 | 33,231,696 | |
| 2025-09-30 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -1,809,667 | 14,597,161 | -11.03 | 3.41 | -6,170,964 | 49,776,319 | |
| 2025-09-19 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -3,596,892 | 8,520,537 | -29.68 | 3.68 | -13,236,563 | 31,355,576 | |
| 2025-09-19 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
S - Sale | -1,403,360 | 12,117,429 | -10.38 | 3.86 | -5,416,970 | 46,773,276 | |
| 2025-09-19 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 17,385,257 | 82,164,767 | 26.84 | ||||
| 2025-03-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 174,825 | 64,779,510 | 0.27 | ||||
| 2025-03-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 57,471 | 64,604,685 | 0.09 | 1.74 | 100,000 | 112,412,152 | |
| 2024-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 23,529,411 | 64,547,214 | 57.36 | 0.85 | 19,999,999 | 54,865,132 | |
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 6,085,471 | 6,085,471 | |||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 8,896,412 | 41,017,803 | 27.70 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -691,929 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -1,383,858 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -832,500 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -2,497,500 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -4,995,000 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -19,711 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -59,133 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -118,266 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -8,790,674 | 0 | -100.00 | ||||
| 2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -58,800 | 0 | -100.00 | ||||
| 2024-03-18 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 69,930 | 32,121,391 | 0.22 | 1.43 | 100,000 | 45,933,589 | |
| 2024-03-12 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 213,675 | 32,051,461 | 0.67 | ||||
| 2023-12-29 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 96,686 | 1,096,686 | 9.67 | 1.41 | 136,327 | 1,546,327 | |
| 2023-08-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 119,411 | 31,837,786 | 0.38 | 1.51 | 180,311 | 48,075,057 | |
| 2023-08-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 200,000 | 31,718,375 | 0.63 | 1.52 | 304,000 | 48,211,930 | |
| 2023-08-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 80,589 | 31,518,375 | 0.26 | 1.53 | 123,301 | 48,223,114 | |
| 2023-08-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 100,000 | 31,437,786 | 0.32 | 1.50 | 150,000 | 47,156,679 | |
| 2023-03-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 85,470 | 31,337,786 | 0.27 | 1.17 | 100,000 | 36,665,210 | |
| 2023-02-24 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 123,152 | 31,252,316 | 0.40 | ||||
| 2023-01-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 11,428,571 | 31,129,164 | 58.01 | 1.75 | 19,999,999 | 54,476,037 | |
| 2023-01-06 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 3,443 | 19,700,593 | 0.02 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 26,361 | 1,015,604 | 2.66 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 6,326 | 453,731 | 1.41 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 8,435 | 351,120 | 2.46 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 10,544 | 578,079 | 1.86 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 10,544 | 578,079 | 1.86 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 42,177 | 1,637,040 | 2.64 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 42,177 | 1,637,040 | 2.64 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 105,445 | 3,944,437 | 2.75 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 105,445 | 3,944,437 | 2.75 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 10,544 | 489,438 | 2.20 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 660,091 | 19,697,150 | 3.47 | ||||
| 2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 26,374 | 1,015,626 | 2.67 | ||||
| 2022-03-28 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
M - Exercise | -32,425 | 0 | -100.00 | ||||
| 2022-03-28 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 32,425 | 19,037,059 | 0.17 | ||||
| 2022-02-24 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
A - Award | 123,152 | 123,152 | |||||
| 2022-02-24 |
|
4 | PGEN |
PRECIGEN, INC.
Option to Purchase Common Stock (Right to Buy) |
A - Award | 166,378 | 166,378 | |||||
| 2022-02-24 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 49,261 | 19,004,634 | 0.26 | 2.03 | 100,000 | 38,579,407 | |
| 2022-01-05 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
M - Exercise | 3,444 | 3,444 | |||||
| 2022-01-05 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 3,444 | 18,741,568 | 0.02 | ||||
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -9,042 | 3,747 | -70.70 | 2.10 | -18,988 | 7,869 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -18,082 | 7,493 | -70.70 | 2.10 | -37,972 | 15,735 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -7,323 | 3,035 | -70.70 | 2.10 | -15,378 | 6,374 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -14,644 | 6,068 | -70.70 | 2.10 | -30,752 | 12,743 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -33,347 | 13,562 | -71.09 | 2.10 | -70,029 | 28,480 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -8,810 | 3,651 | -70.70 | 2.10 | -18,501 | 7,667 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -26,430 | 10,953 | -70.70 | 2.10 | -55,503 | 23,001 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -52,859 | 21,906 | -70.70 | 2.10 | -111,004 | 46,003 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -209 | 86 | -70.85 | 2.10 | -439 | 181 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -626 | 259 | -70.73 | 2.10 | -1,315 | 544 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -1,251 | 519 | -70.68 | 2.10 | -2,627 | 1,090 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -3,294 | 1,365 | -70.70 | 2.10 | -6,917 | 2,866 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -14 | 6 | -70.00 | 2.10 | -29 | 13 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -67,291 | 27,886 | -70.70 | 2.10 | -141,311 | 58,561 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -4,269,495 | 1,769,343 | -70.70 | 2.10 | -8,965,940 | 3,715,620 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -53,028 | 21,976 | -70.70 | 2.10 | -111,359 | 46,150 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -444,702 | 184,291 | -70.70 | 2.10 | -933,874 | 387,011 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -249,384 | 103,349 | -70.70 | 2.10 | -523,706 | 217,033 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -2,262 | 937 | -70.71 | 2.10 | -4,750 | 1,968 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -54,462 | 22,570 | -70.70 | 2.10 | -114,370 | 47,397 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -1,002,663 | 340,514 | -74.65 | 2.10 | -2,105,592 | 715,079 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -980,473 | 331,318 | -74.74 | 2.10 | -2,058,993 | 695,768 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -280,018 | 116,044 | -70.70 | 2.10 | -588,038 | 243,692 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -279,121 | 115,672 | -70.70 | 2.10 | -586,154 | 242,911 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -278,618 | 115,463 | -70.70 | 2.10 | -585,098 | 242,472 | |
| 2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -4,742,552 | 1,965,386 | -70.70 | 2.10 | -9,959,359 | 4,127,311 | |
| 2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 486,335 | 1,000,000 | 94.68 | 3.58 | 1,741,079 | 3,580,000 | |
| 2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 200 | 513,665 | 0.04 | 3.52 | 704 | 1,808,101 | |
| 2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 43,900 | 513,465 | 9.35 | 3.60 | 158,040 | 1,848,474 | |
| 2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 161,904 | 469,565 | 52.62 | 3.59 | 581,235 | 1,685,738 | |
| 2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 307,661 | 307,661 | 3.75 | 1,153,729 | 1,153,729 | ||
| 2021-09-24 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
M - Exercise | 53,571 | 53,571 | |||||
| 2021-09-24 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 53,571 | 18,738,124 | 0.29 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 14,168 | 989,252 | 1.45 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 14,159 | 989,243 | 1.45 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 4,531 | 342,685 | 1.34 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 5,663 | 567,535 | 1.01 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 5,663 | 567,535 | 1.01 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 22,655 | 1,594,863 | 1.44 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 22,655 | 1,594,863 | 1.44 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 56,638 | 3,838,992 | 1.50 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 56,638 | 3,838,992 | 1.50 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 3,398 | 447,405 | 0.77 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 5,663 | 479,857 | 1.19 | ||||
| 2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 354,557 | 18,684,553 | 1.93 | ||||
| 2021-03-29 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
A - Award | 32,425 | 32,425 | |||||
| 2021-03-29 |
|
4 | PGEN |
PRECIGEN, INC.
Option to Purchase Common Stock (Right to Buy) |
A - Award | 44,214 | 44,214 | |||||
| 2021-03-29 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 12,970 | 18,329,996 | 0.07 | 7.71 | 99,999 | 141,324,269 | |
| 2021-03-12 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Option to Purchase Common Stock (Right to Buy) |
A - Award | 2,500 | 2,500 | |||||
| 2021-01-05 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
M - Exercise | 3,444 | 6,887 | 100.03 | ||||
| 2021-01-05 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 3,444 | 18,317,026 | 0.02 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 122 | 11,917 | 1.03 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 10,358 | 10,358 | |||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 242 | 44,543 | 0.55 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 242 | 44,543 | 0.55 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20,712 | 44,301 | 87.80 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20,712 | 44,301 | 87.80 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 24 | 5,866 | 0.41 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 3,328 | 5,842 | 132.38 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 121 | 15,939 | 0.76 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 152 | 17,758 | 0.86 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 42 | 4,583 | 0.92 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 42 | 4,583 | 0.92 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1,848 | 4,541 | 68.62 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1,848 | 4,541 | 68.62 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 42 | 3,204 | 1.33 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 30 | 3,831 | 0.79 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 303 | 40,540 | 0.75 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 303 | 40,540 | 0.75 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 18,482 | 40,237 | 84.96 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 18,482 | 40,237 | 84.96 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1,704 | 318,199 | 0.54 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 70,092 | 316,495 | 28.45 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | -3,637 | 0 | -100.00 | ||||
| 2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | -199,682 | 0 | -100.00 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 8,100 | 1,260,538 | 0.65 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 8,100 | 1,260,538 | 0.65 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 691,929 | 691,929 | |||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 16,200 | 2,976,063 | 0.55 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 16,200 | 2,976,063 | 0.55 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1,383,857 | 2,959,863 | 87.81 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1,383,858 | 1,383,858 | |||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1,620 | 444,007 | 0.37 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 222,264 | 442,387 | 100.97 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 10,125 | 1,572,208 | 0.65 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 2,835 | 561,872 | 0.51 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 2,835 | 561,872 | 0.51 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 123,476 | 559,037 | 28.35 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 123,476 | 559,037 | 28.35 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 2,835 | 473,231 | 0.60 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 2,025 | 338,154 | 0.60 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 20,250 | 3,782,354 | 0.54 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 20,250 | 3,782,354 | 0.54 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1,234,757 | 3,762,104 | 48.86 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1,234,757 | 3,762,104 | 48.86 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 113,716 | 18,313,582 | 0.62 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 4,682,816 | 18,199,866 | 34.64 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -243,001 | 0 | -100.00 | ||||
| 2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -13,340,645 | 0 | -100.00 | ||||
| 2020-09-28 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
A - Award | 53,571 | 53,571 | |||||
| 2020-09-28 |
|
4 | PGEN |
PRECIGEN, INC.
Option to Purchase Common Stock (Right to Buy) |
A - Award | 74,656 | 74,656 | |||||
| 2020-09-28 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 21,428 | 13,517,050 | 0.16 | 3.50 | 74,998 | 47,309,675 | |
| 2020-08-13 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
P - Purchase | 4,000,000 | 9,175,000 | 77.29 | 2.50 | 10,000,000 | 22,937,500 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 1,664 | 220,123 | 0.76 | 4.26 | 7,089 | 937,724 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 1,993 | 212,653 | 0.95 | 4.26 | 8,490 | 905,902 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 10,779 | 435,561 | 2.54 | 4.26 | 45,919 | 1,855,490 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 8,952 | 1,562,083 | 0.58 | 4.26 | 38,136 | 6,654,474 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 30,514 | 2,527,347 | 1.22 | 4.26 | 129,990 | 10,766,498 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 10,792 | 470,396 | 2.35 | 4.26 | 45,974 | 2,003,887 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 16,824 | 1,581,431 | 1.08 | 4.26 | 71,670 | 6,736,896 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 29,652 | 2,286,308 | 1.31 | 4.26 | 126,318 | 9,739,672 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 10,775 | 471,359 | 2.34 | 4.26 | 45,902 | 2,007,989 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 278,921 | 13,495,622 | 2.11 | 4.26 | 1,188,203 | 57,491,350 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 3,355 | 218,459 | 1.56 | 4.50 | 15,098 | 983,066 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 4,018 | 210,660 | 1.94 | 4.50 | 18,081 | 947,970 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 21,741 | 424,782 | 5.39 | 4.50 | 97,834 | 1,911,519 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 18,054 | 1,553,131 | 1.18 | 4.50 | 81,243 | 6,989,090 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 61,544 | 2,496,833 | 2.53 | 4.50 | 276,948 | 11,235,748 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 21,765 | 459,604 | 4.97 | 4.50 | 97,942 | 2,068,218 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 33,934 | 1,564,607 | 2.22 | 4.50 | 152,703 | 7,040,732 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 59,806 | 2,256,656 | 2.72 | 4.50 | 269,127 | 10,154,952 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 21,733 | 460,584 | 4.95 | 4.50 | 97,798 | 2,072,628 | |
| 2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 562,568 | 13,216,701 | 4.45 | 4.50 | 2,531,556 | 59,475,154 | |
| 2020-05-18 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Option to Purchase Common Stock |
A - Award | 2,000 | 2,000 | |||||
| 2020-04-02 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 76,628 | 10,588,601 | 0.73 | 2.61 | 199,999 | 27,636,249 | |
| 2020-03-20 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 420,336 | 10,511,973 | 4.17 | 2.72 | 1,143,314 | 28,592,567 | |
| 2020-03-20 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 79,664 | 10,091,637 | 0.80 | 2.05 | 163,311 | 20,687,856 | |
| 2020-03-20 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 500,000 | 10,011,973 | 5.26 | 1.87 | 935,000 | 18,722,390 | |
| 2020-03-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 45,571 | 22,730,215 | 0.20 | 4.39 | 200,057 | 99,785,644 | |
| 2020-02-18 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
P - Purchase | 5,175,000 | 5,175,000 | 1.50 | 7,762,500 | 7,762,500 | ||
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 24,787 | 182,200 | 15.75 | 5.86 | 145,252 | 1,067,692 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 29,684 | 151,802 | 24.31 | 5.86 | 173,948 | 889,560 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 160,606 | 337,234 | 90.93 | 5.86 | 941,151 | 1,976,191 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 133,370 | 1,299,267 | 11.44 | 5.86 | 781,548 | 7,613,705 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 454,642 | 1,832,054 | 33.01 | 5.86 | 2,664,202 | 10,735,836 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 160,785 | 366,548 | 78.14 | 5.86 | 942,200 | 2,147,971 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 250,674 | 1,316,798 | 23.51 | 5.86 | 1,468,950 | 7,716,436 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 441,800 | 1,675,873 | 35.80 | 5.86 | 2,588,948 | 9,820,616 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 160,546 | 367,560 | 77.55 | 5.86 | 940,800 | 2,153,902 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 4,155,802 | 22,684,644 | 22.43 | 5.86 | 24,353,000 | 132,932,014 | |
| 2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 33,223 | 18,528,842 | 0.18 | 6.02 | 200,002 | 111,543,629 | |
| 2020-01-07 |
|
4 | XON |
INTREXON CORP
Restricted Stock Units |
M - Exercise | 3,443 | 10,332 | 49.98 | ||||
| 2020-01-07 |
|
4 | XON |
INTREXON CORP
Common Stock |
M - Exercise | 3,443 | 18,495,619 | 0.02 | ||||
| 2020-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 141,445 | 3,188,586 | 4.64 | 5.66 | 800,579 | 18,047,397 | |
| 2020-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 34,434 | 18,492,176 | 0.19 | 5.81 | 200,062 | 107,439,543 | |
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -1,161 | 0 | -100.00 | ||||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -1,746 | 0 | -100.00 | ||||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -3 | 0 | -100.00 | ||||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -106 | 0 | -100.00 | ||||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
U - Other | -539,337 | 0 | -100.00 | 3.00 | -1,618,011 | ||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
C - Conversion | 112,617 | 539,337 | 26.39 | ||||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
U - Other | -1,324,328 | 0 | -100.00 | 3.00 | -3,972,984 | ||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
C - Conversion | 169,602 | 1,324,328 | 14.69 | ||||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
U - Other | -2,453 | 0 | -100.00 | 3.00 | -7,359 | ||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
C - Conversion | 291 | 2,453 | 13.46 | ||||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
U - Other | -80,160 | 0 | -100.00 | 3.00 | -240,480 | ||
| 2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
C - Conversion | 10,282 | 80,160 | 14.71 | ||||
| 2019-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 149,543 | 3,047,141 | 5.16 | 5.35 | 800,055 | 16,302,204 | |
| 2019-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 35,536 | 18,457,742 | 0.19 | 5.63 | 200,068 | 103,917,087 | |
| 2019-11-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 134,628 | 2,897,598 | 4.87 | 5.94 | 799,690 | 17,211,732 | |
| 2019-11-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 36,069 | 18,422,206 | 0.20 | 5.54 | 199,822 | 102,059,021 | |
| 2019-10-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 130,761 | 2,762,970 | 4.97 | 6.12 | 800,257 | 16,909,376 | |
| 2019-10-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 33,373 | 18,386,137 | 0.18 | 5.99 | 199,904 | 110,132,961 | |
| 2019-09-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 107,265 | 2,632,209 | 4.25 | 7.46 | 800,197 | 19,636,279 | |
| 2019-09-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 30,088 | 18,352,764 | 0.16 | 6.65 | 200,085 | 122,045,881 | |
| 2019-08-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 102,477 | 2,524,944 | 4.23 | 7.81 | 800,345 | 19,719,813 | |
| 2019-08-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 25,758 | 18,322,676 | 0.14 | 7.76 | 199,882 | 142,183,966 | |
| 2019-07-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 146,487 | 2,422,517 | 6.44 | 5.46 | 799,819 | 13,226,943 | |
| 2019-07-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 28,467 | 18,296,918 | 0.16 | 7.03 | 200,123 | 128,627,334 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 29,647 | 1,142,758 | 2.66 | 5.26 | 155,943 | 6,010,907 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 59,295 | 975,084 | 6.47 | 5.26 | 311,892 | 5,128,942 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 59,295 | 975,084 | 6.47 | 5.26 | 311,892 | 5,128,942 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34,788 | 1,113,111 | 3.23 | 5.23 | 181,941 | 5,821,571 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 69,577 | 915,789 | 8.22 | 5.23 | 363,888 | 4,789,576 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 69,577 | 915,789 | 8.22 | 5.23 | 363,888 | 4,789,576 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,201 | 157,413 | 0.77 | 5.26 | 6,317 | 827,992 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,483 | 122,118 | 2.08 | 5.26 | 13,061 | 642,341 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,328 | 176,628 | 1.92 | 5.26 | 17,505 | 929,063 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12,089 | 1,165,897 | 1.05 | 5.26 | 63,588 | 6,132,618 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 27,846 | 1,377,412 | 2.06 | 5.26 | 146,470 | 7,245,187 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,387 | 205,763 | 1.67 | 5.26 | 17,816 | 1,082,313 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 11,911 | 1,066,124 | 1.13 | 5.26 | 62,652 | 5,607,812 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 26,779 | 1,234,073 | 2.22 | 5.26 | 140,858 | 6,491,224 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,528 | 207,014 | 1.73 | 5.26 | 18,557 | 1,088,894 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 129,803 | 18,268,451 | 0.72 | 5.26 | 682,764 | 96,092,052 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,409 | 156,212 | 0.91 | 5.23 | 7,369 | 816,989 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,914 | 119,635 | 2.50 | 5.23 | 15,240 | 625,691 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,905 | 173,300 | 2.31 | 5.23 | 20,423 | 906,359 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 14,185 | 1,153,808 | 1.24 | 5.23 | 74,188 | 6,034,416 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 32,675 | 1,349,566 | 2.48 | 5.23 | 170,890 | 7,058,230 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,975 | 202,376 | 2.00 | 5.23 | 20,789 | 1,058,426 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 13,976 | 1,054,213 | 1.34 | 5.23 | 73,094 | 5,513,534 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 31,423 | 1,207,294 | 2.67 | 5.23 | 164,342 | 6,314,148 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4,140 | 203,486 | 2.08 | 5.23 | 21,652 | 1,064,232 | |
| 2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 152,311 | 18,138,648 | 0.85 | 5.23 | 796,587 | 94,865,129 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 9,024 | 1,078,323 | 0.84 | 5.17 | 46,654 | 5,574,930 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18,048 | 846,212 | 2.18 | 5.17 | 93,308 | 4,374,916 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18,048 | 846,212 | 2.18 | 5.17 | 93,308 | 4,374,916 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18,086 | 1,069,299 | 1.72 | 4.78 | 86,451 | 5,111,249 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 36,171 | 828,164 | 4.57 | 4.78 | 172,897 | 3,958,624 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 36,171 | 828,164 | 4.57 | 4.78 | 172,897 | 3,958,624 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 365 | 154,803 | 0.24 | 5.17 | 1,887 | 800,332 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 755 | 116,721 | 0.65 | 5.17 | 3,903 | 603,448 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,014 | 169,395 | 0.60 | 5.17 | 5,242 | 875,772 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,679 | 1,139,623 | 0.32 | 5.17 | 19,020 | 5,891,851 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8,476 | 1,316,891 | 0.65 | 5.17 | 43,821 | 6,808,326 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,032 | 198,401 | 0.52 | 5.17 | 5,335 | 1,025,733 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,624 | 1,040,237 | 0.35 | 5.17 | 18,736 | 5,378,025 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8,152 | 1,175,871 | 0.70 | 5.17 | 42,146 | 6,079,253 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,074 | 199,346 | 0.54 | 5.17 | 5,553 | 1,030,619 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 39,508 | 17,986,337 | 0.22 | 5.17 | 204,256 | 92,989,362 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 184,889 | 2,276,030 | 8.84 | 4.33 | 800,569 | 9,855,210 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 732 | 154,438 | 0.48 | 4.78 | 3,499 | 738,214 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,515 | 115,966 | 1.32 | 4.78 | 7,242 | 554,317 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,030 | 168,381 | 1.22 | 4.78 | 9,703 | 804,861 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7,374 | 1,135,944 | 0.65 | 4.78 | 35,248 | 5,429,812 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16,987 | 1,308,415 | 1.32 | 4.78 | 81,198 | 6,254,224 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,066 | 197,369 | 1.06 | 4.78 | 9,875 | 943,424 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7,266 | 1,036,613 | 0.71 | 4.78 | 34,731 | 4,955,010 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16,336 | 1,167,719 | 1.42 | 4.78 | 78,086 | 5,581,697 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,152 | 198,272 | 1.10 | 4.78 | 10,287 | 947,740 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 44,283 | 17,946,829 | 0.25 | 4.52 | 200,159 | 81,119,667 | |
| 2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 79,184 | 17,902,546 | 0.44 | 4.78 | 378,500 | 85,574,170 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,661 | 153,706 | 1.09 | 4.79 | 7,956 | 736,252 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,435 | 114,451 | 3.09 | 4.79 | 16,454 | 548,220 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4,604 | 166,351 | 2.85 | 4.79 | 22,053 | 796,821 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16,723 | 1,128,570 | 1.50 | 4.79 | 80,103 | 5,405,850 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 38,521 | 1,291,428 | 3.07 | 4.79 | 184,516 | 6,185,940 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4,686 | 195,303 | 2.46 | 4.79 | 22,446 | 935,501 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16,477 | 1,029,347 | 1.63 | 4.79 | 78,925 | 4,930,572 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 37,044 | 1,151,383 | 3.32 | 4.79 | 177,441 | 5,515,125 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4,880 | 196,120 | 2.55 | 4.79 | 23,375 | 939,415 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 179,561 | 17,823,362 | 1.02 | 4.79 | 860,097 | 85,373,904 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,013 | 152,045 | 0.67 | 4.68 | 4,741 | 711,571 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,096 | 111,016 | 1.92 | 4.68 | 9,809 | 519,555 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,809 | 161,747 | 1.77 | 4.68 | 13,146 | 756,976 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 10,204 | 1,111,847 | 0.93 | 4.68 | 47,755 | 5,203,444 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 23,504 | 1,252,907 | 1.91 | 4.68 | 109,999 | 5,863,605 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,859 | 190,617 | 1.52 | 4.68 | 13,380 | 892,088 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 10,053 | 1,012,870 | 1.00 | 4.68 | 47,048 | 4,740,232 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 22,603 | 1,114,339 | 2.07 | 4.68 | 105,782 | 5,215,107 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,978 | 191,240 | 1.58 | 4.68 | 13,937 | 895,003 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 109,560 | 17,643,801 | 0.62 | 4.68 | 512,741 | 82,572,989 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 41,012 | 1,051,213 | 4.06 | 4.79 | 196,447 | 5,035,310 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 82,024 | 791,993 | 11.55 | 4.79 | 392,895 | 3,793,646 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 82,024 | 791,993 | 11.55 | 4.79 | 392,895 | 3,793,646 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 25,024 | 1,010,201 | 2.54 | 4.68 | 117,112 | 4,727,741 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 50,048 | 709,969 | 7.58 | 4.68 | 234,225 | 3,322,655 | |
| 2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 50,048 | 709,969 | 7.58 | 4.68 | 234,225 | 3,322,655 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 14,486 | 985,177 | 1.49 | 4.68 | 67,794 | 4,610,628 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 28,972 | 659,921 | 4.59 | 4.68 | 135,589 | 3,088,430 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 28,972 | 659,921 | 4.59 | 4.68 | 135,589 | 3,088,430 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 17,150 | 970,691 | 1.80 | 4.67 | 80,090 | 4,533,127 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34,300 | 630,949 | 5.75 | 4.67 | 160,181 | 2,946,532 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34,300 | 630,949 | 5.75 | 4.67 | 160,181 | 2,946,532 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 23,037 | 953,541 | 2.48 | 4.70 | 108,274 | 4,481,643 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 46,075 | 596,649 | 8.37 | 4.70 | 216,552 | 2,804,250 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 46,075 | 596,649 | 8.37 | 4.70 | 216,552 | 2,804,250 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 587 | 151,032 | 0.39 | 4.68 | 2,747 | 706,830 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,213 | 108,920 | 1.13 | 4.68 | 5,677 | 509,746 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,626 | 158,938 | 1.03 | 4.68 | 7,610 | 743,830 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 5,907 | 1,101,643 | 0.54 | 4.68 | 27,645 | 5,155,689 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 13,606 | 1,229,403 | 1.12 | 4.68 | 63,676 | 5,753,606 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,655 | 187,758 | 0.89 | 4.68 | 7,745 | 878,707 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 5,820 | 1,002,817 | 0.58 | 4.68 | 27,238 | 4,693,184 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 13,084 | 1,091,736 | 1.21 | 4.68 | 61,233 | 5,109,324 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,724 | 188,262 | 0.92 | 4.68 | 8,068 | 881,066 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 63,423 | 17,534,241 | 0.36 | 4.68 | 296,820 | 82,060,248 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 695 | 150,445 | 0.46 | 4.67 | 3,246 | 702,578 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,436 | 107,707 | 1.35 | 4.67 | 6,706 | 502,992 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,925 | 157,312 | 1.24 | 4.67 | 8,990 | 734,647 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6,993 | 1,095,736 | 0.64 | 4.67 | 32,657 | 5,117,087 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16,108 | 1,215,797 | 1.34 | 4.67 | 75,224 | 5,677,772 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,959 | 186,103 | 1.06 | 4.67 | 9,149 | 869,101 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6,890 | 996,997 | 0.70 | 4.67 | 32,176 | 4,655,976 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 15,491 | 1,078,652 | 1.46 | 4.67 | 72,343 | 5,037,305 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,041 | 186,538 | 1.11 | 4.67 | 9,531 | 871,132 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 75,088 | 17,470,818 | 0.43 | 4.67 | 350,661 | 81,588,720 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 933 | 149,750 | 0.63 | 4.70 | 4,385 | 703,825 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,929 | 106,271 | 1.85 | 4.70 | 9,066 | 499,474 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,586 | 155,387 | 1.69 | 4.70 | 12,154 | 730,319 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 9,393 | 1,088,743 | 0.87 | 4.70 | 44,147 | 5,117,092 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 21,638 | 1,199,689 | 1.84 | 4.70 | 101,699 | 5,638,538 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,632 | 184,144 | 1.45 | 4.70 | 12,370 | 865,477 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 9,255 | 990,107 | 0.94 | 4.70 | 43,498 | 4,653,503 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 20,808 | 1,063,161 | 2.00 | 4.70 | 97,798 | 4,996,857 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,741 | 184,497 | 1.51 | 4.70 | 12,883 | 867,136 | |
| 2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 100,864 | 17,395,730 | 0.58 | 4.70 | 474,061 | 81,759,931 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12,045 | 930,504 | 1.31 | 4.74 | 57,093 | 4,410,589 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24,089 | 550,574 | 4.58 | 4.74 | 114,182 | 2,609,721 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24,089 | 550,574 | 4.58 | 4.74 | 114,182 | 2,609,721 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 60,334 | 918,459 | 7.03 | 4.63 | 279,346 | 4,252,465 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 120,668 | 526,485 | 29.73 | 4.63 | 558,693 | 2,437,626 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 120,668 | 526,485 | 29.73 | 4.63 | 558,693 | 2,437,626 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12,106 | 858,125 | 1.43 | 4.69 | 56,777 | 4,024,606 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24,212 | 405,817 | 6.34 | 4.69 | 113,554 | 1,903,282 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24,212 | 405,817 | 6.34 | 4.69 | 113,554 | 1,903,282 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 488 | 148,817 | 0.33 | 4.74 | 2,313 | 705,393 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,009 | 104,342 | 0.98 | 4.74 | 4,783 | 494,581 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,352 | 152,801 | 0.89 | 4.74 | 6,408 | 724,277 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4,911 | 1,079,350 | 0.46 | 4.74 | 23,278 | 5,116,119 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 11,313 | 1,178,051 | 0.97 | 4.74 | 53,624 | 5,583,962 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,376 | 181,512 | 0.76 | 4.74 | 6,522 | 860,367 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4,839 | 980,852 | 0.50 | 4.74 | 22,937 | 4,649,238 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 10,879 | 1,042,353 | 1.05 | 4.74 | 51,566 | 4,940,753 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,433 | 181,756 | 0.79 | 4.74 | 6,792 | 861,523 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 52,735 | 17,294,866 | 0.31 | 4.74 | 249,964 | 81,977,665 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,444 | 148,329 | 1.68 | 4.63 | 11,316 | 686,763 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 5,053 | 103,333 | 5.14 | 4.63 | 23,395 | 478,432 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6,772 | 151,449 | 4.68 | 4.63 | 31,354 | 701,209 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24,601 | 1,074,439 | 2.34 | 4.63 | 113,903 | 4,974,653 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 56,668 | 1,166,738 | 5.10 | 4.63 | 262,373 | 5,401,997 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6,893 | 180,136 | 3.98 | 4.63 | 31,915 | 834,030 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24,239 | 976,013 | 2.55 | 4.63 | 112,227 | 4,518,940 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 54,496 | 1,031,474 | 5.58 | 4.63 | 252,316 | 4,775,725 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7,180 | 180,323 | 4.15 | 4.63 | 33,243 | 834,895 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 264,156 | 17,242,131 | 1.56 | 4.63 | 1,223,042 | 79,831,067 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 490 | 145,885 | 0.34 | 4.69 | 2,298 | 684,201 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,014 | 98,280 | 1.04 | 4.69 | 4,756 | 460,933 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,359 | 144,677 | 0.95 | 4.69 | 6,374 | 678,535 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4,936 | 1,049,838 | 0.47 | 4.69 | 23,150 | 4,923,740 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 11,370 | 1,110,070 | 1.03 | 4.69 | 53,325 | 5,206,228 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,383 | 173,243 | 0.80 | 4.69 | 6,486 | 812,510 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4,864 | 951,774 | 0.51 | 4.69 | 22,812 | 4,463,820 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 10,935 | 976,978 | 1.13 | 4.69 | 51,285 | 4,582,027 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,441 | 173,143 | 0.84 | 4.69 | 6,758 | 812,041 | |
| 2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 53,002 | 16,977,975 | 0.31 | 4.69 | 248,579 | 79,626,703 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 62,810 | 846,019 | 8.02 | 4.59 | 288,298 | 3,883,227 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 125,620 | 381,605 | 49.07 | 4.59 | 576,596 | 1,751,567 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 125,620 | 94,620,773 | 0.13 | 4.59 | 576,596 | 434,309,348 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 29,500 | 783,209 | 3.91 | 4.37 | 128,915 | 3,422,623 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 59,000 | 255,985 | 29.95 | 4.37 | 257,830 | 1,118,654 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 59,000 | 255,985 | 29.95 | 4.37 | 257,830 | 1,118,654 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 75,386 | 753,709 | 11.11 | 4.25 | 320,390 | 3,203,263 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 150,773 | 196,985 | 326.26 | 4.25 | 640,785 | 837,186 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 150,773 | 196,985 | 326.26 | 4.25 | 640,785 | 837,186 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,544 | 145,395 | 1.78 | 4.59 | 11,677 | 667,363 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 5,260 | 97,266 | 5.72 | 4.59 | 24,143 | 446,451 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7,050 | 143,318 | 5.17 | 4.59 | 32,360 | 657,830 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 25,611 | 1,044,902 | 2.51 | 4.59 | 117,554 | 4,796,100 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 58,994 | 1,098,700 | 5.67 | 4.59 | 270,782 | 5,043,033 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7,176 | 171,860 | 4.36 | 4.59 | 32,938 | 788,837 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 25,234 | 946,910 | 2.74 | 4.59 | 115,824 | 4,346,317 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 56,733 | 966,043 | 6.24 | 4.59 | 260,404 | 4,434,137 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7,474 | 171,702 | 4.55 | 4.59 | 34,306 | 788,112 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 275,001 | 16,924,973 | 1.65 | 4.59 | 1,262,255 | 77,685,626 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,195 | 142,851 | 0.84 | 4.37 | 5,222 | 624,259 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,471 | 92,006 | 2.76 | 4.37 | 10,798 | 402,066 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,311 | 136,268 | 2.49 | 4.37 | 14,469 | 595,491 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12,029 | 1,019,291 | 1.19 | 4.37 | 52,567 | 4,454,302 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 27,708 | 1,039,706 | 2.74 | 4.37 | 121,084 | 4,543,515 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,370 | 164,684 | 2.09 | 4.37 | 14,727 | 719,669 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 11,852 | 921,676 | 1.30 | 4.37 | 51,793 | 4,027,724 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 26,646 | 909,310 | 3.02 | 4.37 | 116,443 | 3,973,685 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,511 | 164,228 | 2.18 | 4.37 | 15,343 | 717,676 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 129,158 | 16,649,972 | 0.78 | 4.37 | 564,420 | 72,760,378 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3,053 | 141,656 | 2.20 | 4.25 | 12,975 | 602,038 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6,314 | 89,535 | 7.59 | 4.25 | 26,834 | 380,524 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8,462 | 132,957 | 6.80 | 4.25 | 35,964 | 565,067 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 30,739 | 1,007,262 | 3.15 | 4.25 | 130,641 | 4,280,864 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 70,807 | 1,011,998 | 7.52 | 4.25 | 300,930 | 4,300,992 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8,613 | 161,314 | 5.64 | 4.25 | 36,605 | 685,584 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 30,287 | 909,824 | 3.44 | 4.25 | 128,720 | 3,866,752 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 68,093 | 882,664 | 8.36 | 4.25 | 289,395 | 3,751,322 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8,971 | 160,717 | 5.91 | 4.25 | 38,127 | 683,047 | |
| 2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 330,060 | 16,520,814 | 2.04 | 4.25 | 1,402,755 | 70,213,460 | |
| 2019-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 508,617 | 2,091,141 | 32.14 | ||||
| 2019-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 43,887 | 16,190,754 | 0.27 | 4.56 | 200,125 | 73,829,838 | |
| 2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -69,161 | 165,332 | -29.49 | 0.65 | -44,955 | 107,466 | |
| 2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -26,080 | 62,342 | -29.49 | 0.65 | -16,952 | 40,522 | |
| 2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -9,909 | 234,493 | -4.05 | 0.66 | -6,540 | 154,765 | |
| 2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -3,737 | 88,422 | -4.05 | 0.66 | -2,466 | 58,359 | |
| 2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -30,265 | 244,402 | -11.02 | 0.67 | -20,278 | 163,749 | |
| 2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -11,413 | 92,159 | -11.02 | 0.67 | -7,647 | 61,747 | |
| 2019-04-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 38,022 | 16,146,867 | 0.24 | 5.26 | 199,996 | 84,932,520 | |
| 2019-03-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 25,094 | 16,108,845 | 0.16 | 7.97 | 199,999 | 128,387,495 | |
| 2019-02-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 26,109 | 16,083,751 | 0.16 | 7.66 | 199,995 | 123,201,533 | |
| 2019-01-15 |
|
4 | HSGX |
HISTOGENICS CORP
Common Stock |
S - Sale | -345,897 | 1,692,366 | -16.97 | 0.15 | -51,885 | 253,855 | |
| 2019-01-15 |
|
4 | HSGX |
HISTOGENICS CORP
Common Stock |
S - Sale | -400,507 | 2,038,263 | -16.42 | 0.16 | -64,081 | 326,122 | |
| 2019-01-15 |
|
4 | HSGX |
HISTOGENICS CORP
Common Stock |
S - Sale | -251,800 | 2,438,770 | -9.36 | 0.17 | -42,806 | 414,591 | |
| 2019-01-08 |
|
4 | XON |
INTREXON CORP
Restricted Stock Units |
A - Award | 13,775 | 13,775 | |||||
| 2019-01-08 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 13,774 | 16,057,642 | 0.09 | ||||
| 2019-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 30,581 | 16,043,868 | 0.19 | 6.54 | 200,000 | 104,926,897 | |
| 2019-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 96,501 | 1,582,524 | 6.49 | 8.29 | 799,993 | 13,119,124 | |
| 2018-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 20,408 | 16,013,287 | 0.13 | ||||
| 2018-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 77,594 | 1,486,023 | 5.51 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 7,537 | 83,221 | 9.96 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 10,314 | 124,495 | 9.03 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 46,212 | 46,212 | |||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 46,212 | 46,212 | |||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 36,097 | 976,523 | 3.84 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 90,836 | 941,191 | 10.68 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 12,694 | 152,701 | 9.07 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 12,694 | 152,701 | 9.07 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 3,570 | 138,603 | 2.64 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 36,493 | 879,537 | 4.33 | ||||
| 2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 94,009 | 814,571 | 13.05 | ||||
| 2018-11-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 17,301 | 15,992,879 | 0.11 | 11.56 | 200,000 | 184,877,681 | |
| 2018-11-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 55,478 | 1,408,429 | 4.10 | 14.42 | 799,993 | 20,309,546 | |
| 2018-10-29 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Warrant to Purchase Common Stock |
X - Other | -1,538,461 | 0 | -100.00 | ||||
| 2018-10-29 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
X - Other | 1,538,461 | 8,239,199 | 22.96 | 2.00 | 3,076,922 | 16,478,398 | |
| 2018-10-09 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | -130,849 | 0 | -100.00 | ||||
| 2018-10-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 11,614 | 15,975,578 | 0.07 | 17.22 | 199,993 | 275,099,453 | |
| 2018-10-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 55,904 | 1,352,951 | 4.31 | 14.31 | 799,986 | 19,360,729 | |
| 2018-09-28 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,295 | 130,849 | 1.00 | ||||
| 2018-09-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 13,003 | 15,963,964 | 0.08 | 15.38 | 199,986 | 245,525,766 | |
| 2018-09-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 58,224 | 1,297,047 | 4.70 | 13.74 | 799,998 | 17,821,426 | |
| 2018-08-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,282 | 129,554 | 1.00 | ||||
| 2018-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
S - Sale | -500 | 27,151 | -1.81 | 0.41 | -205 | 11,132 | |
| 2018-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
S - Sale | -4,920 | 266,904 | -1.81 | 0.41 | -2,017 | 109,431 | |
| 2018-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
S - Sale | -9,340 | 506,657 | -1.81 | 0.41 | -3,829 | 207,729 | |
| 2018-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
S - Sale | -9,840 | 533,809 | -1.81 | 0.41 | -4,034 | 218,862 | |
| 2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -256,860 | 1,897,610 | -11.92 | 18.02 | -4,628,617 | 34,194,932 | |
| 2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -175,389 | 3,900,919 | -4.30 | 18.02 | -3,160,510 | 70,294,560 | |
| 2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -64,996 | 2,154,470 | -2.93 | 18.22 | -1,184,227 | 39,254,443 | |
| 2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -44,381 | 4,076,308 | -1.08 | 18.22 | -808,622 | 74,270,332 | |
| 2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -61,428 | 2,219,466 | -2.69 | 18.20 | -1,117,990 | 40,394,281 | |
| 2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -41,944 | 4,120,689 | -1.01 | 18.20 | -763,381 | 74,996,540 | |
| 2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -149,353 | 2,280,894 | -6.15 | 18.48 | -2,760,043 | 42,150,921 | |
| 2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -101,982 | 4,162,633 | -2.39 | 18.48 | -1,884,627 | 76,925,458 | |
| 2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -464,624 | 2,430,247 | -16.05 | 17.49 | -8,126,274 | 42,505,020 | |
| 2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -317,257 | 4,264,615 | -6.92 | 17.49 | -5,548,825 | 74,588,116 | |
| 2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -95,819 | 2,894,871 | -3.20 | 17.15 | -1,643,296 | 49,647,038 | |
| 2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -65,427 | 4,581,872 | -1.41 | 17.15 | -1,122,073 | 78,579,105 | |
| 2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -56,668 | 2,985,054 | -1.86 | 17.24 | -976,956 | 51,462,331 | |
| 2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -38,695 | 4,643,451 | -0.83 | 17.24 | -667,102 | 80,053,095 | |
| 2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -54,397 | 3,041,722 | -1.76 | 17.15 | -932,909 | 52,165,532 | |
| 2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -37,144 | 4,682,146 | -0.79 | 17.15 | -637,020 | 80,298,804 | |
| 2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -180,154 | 3,096,119 | -5.50 | 17.36 | -3,127,473 | 53,748,626 | |
| 2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -123,014 | 4,719,290 | -2.54 | 17.36 | -2,135,523 | 81,926,874 | |
| 2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -120,606 | 3,276,273 | -3.55 | 17.08 | -2,059,950 | 55,958,743 | |
| 2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -82,353 | 4,842,304 | -1.67 | 17.08 | -1,406,589 | 82,706,552 | |
| 2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -132,591 | 3,396,879 | -3.76 | 17.48 | -2,317,691 | 59,377,445 | |
| 2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -90,536 | 4,924,657 | -1.81 | 17.48 | -1,582,569 | 86,083,004 | |
| 2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -87,185 | 3,529,470 | -2.41 | 17.52 | -1,527,481 | 61,836,314 | |
| 2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -59,533 | 5,015,193 | -1.17 | 17.52 | -1,043,018 | 87,866,181 | |
| 2018-08-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 13,642 | 15,950,961 | 0.09 | 14.66 | 199,992 | 233,841,088 | |
| 2018-08-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 52,015 | 1,238,823 | 4.38 | 15.38 | 799,991 | 19,053,098 | |
| 2018-07-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,270 | 128,272 | 1.00 | ||||
| 2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -29,074 | 3,616,655 | -0.80 | 16.90 | -491,351 | 61,121,470 | |
| 2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -19,853 | 5,074,726 | -0.39 | 16.90 | -335,516 | 85,762,869 | |
| 2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -89,136 | 3,645,729 | -2.39 | 17.30 | -1,542,053 | 63,071,112 | |
| 2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -60,864 | 5,094,579 | -1.18 | 17.30 | -1,052,947 | 88,136,217 | |
| 2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -61,741 | 3,734,865 | -1.63 | 17.32 | -1,069,354 | 64,687,862 | |
| 2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -42,159 | 5,155,443 | -0.81 | 17.32 | -730,194 | 89,292,273 | |
| 2018-07-06 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,121,914 | 15,937,319 | 7.57 | 13.37 | 14,999,990 | 213,081,955 | |
| 2018-07-06 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6,357,517 | 14,140,139 | 81.69 | 13.37 | 85,000,002 | 189,053,658 | |
| 2018-07-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 14,347 | 14,815,405 | 0.10 | 13.94 | 199,997 | 206,526,746 | |
| 2018-07-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 49,535 | 1,186,808 | 4.36 | 16.15 | 799,990 | 19,166,949 | |
| 2018-06-29 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,257 | 127,002 | 1.00 | ||||
| 2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -72,753 | 3,796,606 | -1.88 | 16.97 | -1,234,618 | 64,428,404 | |
| 2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -49,678 | 5,197,602 | -0.95 | 16.97 | -843,036 | 88,203,306 | |
| 2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -76,291 | 3,869,359 | -1.93 | 16.99 | -1,296,184 | 65,740,409 | |
| 2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -52,094 | 5,247,280 | -0.98 | 16.99 | -885,077 | 89,151,287 | |
| 2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -31,795 | 3,945,650 | -0.80 | 17.34 | -551,325 | 68,417,571 | |
| 2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -21,710 | 5,299,374 | -0.41 | 17.34 | -376,451 | 91,891,145 | |
| 2018-06-04 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,245 | 125,745 | 1.00 | ||||
| 2018-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 12,062 | 14,801,058 | 0.08 | 16.58 | 199,988 | 245,401,542 | |
| 2018-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 49,382 | 1,137,273 | 4.54 | 16.20 | 799,988 | 18,423,823 | |
| 2018-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 11,001 | 14,788,996 | 0.07 | 18.18 | 199,998 | 268,863,947 | |
| 2018-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 40,774 | 1,087,891 | 3.89 | 19.62 | 799,986 | 21,344,421 | |
| 2018-04-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,232 | 124,500 | 1.00 | ||||
| 2018-04-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 13,046 | 14,777,995 | 0.09 | 15.33 | 199,995 | 226,546,663 | |
| 2018-04-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 47,505 | 1,047,117 | 4.75 | 16.84 | 799,984 | 17,633,450 | |
| 2018-03-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,220 | 123,268 | 1.00 | ||||
| 2018-03-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 15,360 | 14,764,949 | 0.10 | 13.02 | 199,987 | 192,239,636 | |
| 2018-03-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 58,737 | 999,612 | 6.24 | 13.62 | 799,998 | 13,614,715 | |
| 2018-02-28 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,208 | 122,048 | 1.00 | ||||
| 2018-02-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 15,384 | 14,749,589 | 0.10 | 13.00 | 199,992 | 191,744,657 | |
| 2018-02-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 54,384 | 940,875 | 6.13 | 14.71 | 799,989 | 13,840,271 | |
| 2018-01-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,196 | 120,840 | 1.00 | ||||
| 2018-01-22 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1,000,000 | 7,782,622 | 14.74 | 12.50 | 12,500,000 | 97,282,775 | |
| 2018-01-19 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 1,538,461 | 1,538,461 | |||||
| 2018-01-19 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
P - Purchase | 1,538,461 | 6,700,738 | 29.80 | 3.25 | 4,999,998 | 21,777,398 | |
| 2018-01-03 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,184 | 119,644 | 1.00 | ||||
| 2018-01-03 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Option to Purchase Common Stock |
A - Award | 25,000 | 25,000 | |||||
| 2018-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 63,291 | 886,491 | 7.69 | 12.64 | 799,998 | 11,205,246 | |
| 2018-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 17,361 | 14,734,205 | 0.12 | 11.52 | 199,999 | 169,738,042 | |
| 2018-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 1,207,980 | 14,716,844 | 8.94 | 11.33 | 13,686,413 | 166,741,843 | |
| 2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 4,805 | 4,805 | |||||
| 2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 155,347 | 155,347 | |||||
| 2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 2,567,121 | 2,567,121 | |||||
| 2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 4,805 | 10,806 | 80.07 | 0.77 | 3,700 | 8,321 | |
| 2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 155,347 | 349,386 | 80.06 | 0.77 | 119,617 | 269,027 | |
| 2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 2,567,121 | 5,773,626 | 80.06 | 0.77 | 1,976,683 | 4,445,692 | |
| 2017-12-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 14,662 | 13,508,864 | 0.11 | 13.64 | 199,990 | 184,260,905 | |
| 2017-12-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 63,241 | 823,200 | 8.32 | 12.65 | 799,999 | 10,413,480 | |
| 2017-11-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,172 | 118,460 | 1.00 | ||||
| 2017-11-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 12,232 | 13,494,202 | 0.09 | 16.35 | 199,993 | 220,630,203 | |
| 2017-11-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 44,469 | 759,959 | 6.22 | 17.99 | 799,997 | 13,671,662 | |
| 2017-11-01 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,161 | 117,288 | 1.00 | ||||
| 2017-10-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 10,520 | 13,481,970 | 0.08 | 19.01 | 199,985 | 256,292,250 | |
| 2017-10-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 41,300 | 715,490 | 6.13 | 19.37 | 799,981 | 13,859,041 | |
| 2017-09-29 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,149 | 116,127 | 1.00 | ||||
| 2017-09-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 10,136 | 13,471,450 | 0.08 | 19.73 | 199,983 | 265,791,708 | |
| 2017-09-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 42,941 | 674,190 | 6.80 | 18.63 | 799,991 | 12,560,160 | |
| 2017-08-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,138 | 114,978 | 1.00 | ||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 80,292 | 80,292 | |||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
C - Conversion | -162,696 | 0 | -100.00 | ||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 160,585 | 160,585 | |||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 160,585 | 160,585 | |||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
C - Conversion | -325,393 | 0 | -100.00 | ||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
C - Conversion | -325,393 | 0 | -100.00 | ||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
C - Conversion | 162,696 | 271,824 | 149.09 | ||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
C - Conversion | 325,393 | 515,997 | 170.72 | ||||
| 2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
C - Conversion | 325,393 | 515,997 | 170.72 | ||||
| 2017-08-14 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 132,625 | 6,782,622 | 1.99 | 18.85 | 2,499,981 | 127,852,425 | |
| 2017-08-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 9,263 | 13,461,314 | 0.07 | 21.59 | 199,988 | 290,629,769 | |
| 2017-08-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 34,587 | 631,249 | 5.80 | 23.13 | 799,997 | 14,600,789 | |
| 2017-07-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,127 | 113,840 | 1.00 | ||||
| 2017-07-26 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8,325,000 | 8,325,000 | |||||
| 2017-07-26 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8,099,238 | 13,452,051 | 151.31 | ||||
| 2017-07-26 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | -22,636,052 | 0 | -100.00 | ||||
| 2017-07-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 2,327,603 | 2,327,603 | |||||
| 2017-07-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 2,264,483 | 5,321,084 | 74.09 | ||||
| 2017-07-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | -6,328,853 | 0 | -100.00 | ||||
| 2017-07-26 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 124,609 | 124,609 | |||||
| 2017-07-26 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 121,231 | 200,519 | 152.90 | ||||
| 2017-07-26 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | -338,816 | 0 | -100.00 | ||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 0 | ||||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A-1 Convertible Preferred Stock |
C - Conversion | -42,941 | 0 | -100.00 | ||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A-1 Convertible Preferred Stock |
C - Conversion | -42,941 | 0 | -100.00 | ||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
P - Purchase | 160,585 | 160,585 | 3.74 | 600,588 | 600,588 | ||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 160,585 | ||||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 70,526 | ||||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A-1 Convertible Preferred Stock |
C - Conversion | -42,941 | 0 | -100.00 | ||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
P - Purchase | 321,170 | 321,170 | 3.74 | 1,201,176 | 1,201,176 | ||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
P - Purchase | 321,170 | 321,170 | 3.74 | 1,201,176 | 1,201,176 | ||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 321,170 | ||||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 141,052 | ||||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A-1 Convertible Preferred Stock |
C - Conversion | -85,882 | 0 | -100.00 | ||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 321,170 | ||||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 1,431 | 27,651 | 5.46 | ||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 1,431 | 27,651 | 5.46 | ||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 1,431 | 27,651 | 5.46 | ||||
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 70,526 | 107,697 | 189.73 | 15.00 | 1,057,890 | 1,615,455 | |
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 141,052 | 189,173 | 293.12 | 15.00 | 2,115,780 | 2,837,595 | |
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 141,052 | 189,173 | 293.12 | 15.00 | 2,115,780 | 2,837,595 | |
| 2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 2,862 | 218,256 | 1.33 | ||||
| 2017-06-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,115 | 112,713 | 1.00 | ||||
| 2017-06-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 8,302 | 5,352,813 | 0.16 | 24.09 | 199,995 | 128,949,265 | |
| 2017-06-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 35,056 | 596,662 | 6.24 | 22.82 | 799,978 | 13,615,827 | |
| 2017-06-12 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
S - Sale | -108,000 | 786,613 | -12.07 | 1.00 | -108,000 | 786,613 | |
| 2017-06-12 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
S - Sale | -395,000 | 1,115,135 | -26.16 | 1.00 | -395,000 | 1,115,135 | |
| 2017-06-12 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
S - Sale | -682,000 | 1,443,654 | -32.08 | 1.00 | -682,000 | 1,443,654 | |
| 2017-06-12 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
S - Sale | -790,000 | 2,230,267 | -26.16 | 1.00 | -790,000 | 2,230,267 | |
| 2017-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 9,380 | 5,344,511 | 0.18 | 21.32 | 199,982 | 113,944,975 | |
| 2017-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 31,164 | 561,606 | 5.88 | 25.67 | 799,980 | 14,416,426 | |
| 2017-06-01 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,104 | 111,598 | 1.00 | ||||
| 2017-05-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2017-05-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 10,000 | 3,562,388 | 0.28 | 10.37 | 103,700 | 36,941,964 | |
| 2017-05-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 14,135 | 3,552,388 | 0.40 | ||||
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -1,881 | 85,397 | -2.16 | 2.54 | -4,778 | 216,908 | |
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -9,695 | 440,418 | -2.15 | 2.54 | -24,625 | 1,118,662 | |
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -13,893 | 87,278 | -13.73 | 2.70 | -37,511 | 235,651 | |
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -71,607 | 450,113 | -13.73 | 2.70 | -193,339 | 1,215,305 | |
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Warrant to Purchase Common Stock |
X - Other | -250,000 | 0 | -100.00 | ||||
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -2,278 | 101,171 | -2.20 | 2.97 | -6,766 | 300,478 | |
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -11,739 | 521,720 | -2.20 | 2.97 | -34,865 | 1,549,508 | |
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -49,875 | 533,459 | -8.55 | 4.01 | -199,999 | 2,139,171 | |
| 2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
X - Other | 250,000 | 583,334 | 75.00 | 0.80 | 200,000 | 466,667 | |
| 2017-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 9,596 | 5,335,131 | 0.18 | 20.84 | 199,981 | 111,184,130 | |
| 2017-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 40,671 | 530,442 | 8.30 | 19.67 | 799,999 | 10,433,794 | |
| 2017-05-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,094 | 110,494 | 1.00 | ||||
| 2017-04-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 10,090 | 5,325,535 | 0.19 | 19.82 | 199,984 | 105,552,104 | |
| 2017-04-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 37,807 | 489,771 | 8.37 | 21.16 | 799,996 | 10,363,554 | |
| 2017-03-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,083 | 109,400 | 1.00 | ||||
| 2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 1,496,529 | 1,496,529 | |||||
| 2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 2,250,594 | 2,250,594 | |||||
| 2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 3,867 | 3,867 | |||||
| 2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 136,634 | 136,634 | |||||
| 2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred |
P - Purchase | 1,161 | 1,496,529 | 0.08 | ||||
| 2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred |
P - Purchase | 1,746 | 2,250,594 | 0.08 | ||||
| 2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred |
P - Purchase | 3 | 3,867 | 0.08 | ||||
| 2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred |
P - Purchase | 106 | 136,634 | 0.08 | ||||
| 2017-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
G - Gift | -200 | 5,315,445 | 0.00 | ||||
| 2017-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 8,984 | 5,315,645 | 0.17 | 22.26 | 199,984 | 118,326,258 | |
| 2017-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 33,826 | 451,964 | 8.09 | 23.65 | 799,985 | 10,688,949 | |
| 2017-03-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,072 | 108,317 | 1.00 | ||||
| 2017-02-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 9,451 | 5,306,661 | 0.18 | 21.16 | 199,983 | 112,288,947 | |
| 2017-02-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 32,297 | 418,138 | 8.37 | 24.77 | 799,997 | 10,357,278 | |
| 2017-02-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,061 | 107,245 | 1.00 | ||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 3,637 | 3,637 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 199,682 | 199,682 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 338,816 | 338,816 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 10,153 | 10,153 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20,306 | 20,306 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20,306 | 20,306 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 14,076 | 14,076 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 3,199 | 3,199 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 880 | 880 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 82,083 | 82,083 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 99,537 | 99,537 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 295 | 295 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 885 | 885 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1,770 | 1,770 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 2,021 | 2,021 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 12,617 | 12,617 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1,132 | 1,132 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 12,726 | 12,726 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 10,784 | 10,784 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1,708 | 1,708 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 2,095 | 2,095 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 2,080 | 2,080 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20 | 20 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 4,659 | 4,659 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 79,288 | 79,288 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 5,775 | 5,775 | |||||
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
P - Purchase | 2,421,073 | 5,161,247 | 88.35 | 10.33 | 25,009,684 | 53,315,682 | |
| 2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | -1,776,557 | 2,740,174 | -39.33 | ||||
| 2017-01-05 | 3 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
271,003,808 | ||||||||
| 2017-01-05 | 3 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
271,003,808 | ||||||||
| 2017-01-05 | 3 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
271,003,808 | ||||||||
| 2016-12-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 8,230 | 5,297,210 | 0.16 | 24.30 | 199,989 | 128,722,203 | |
| 2016-12-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 28,188 | 385,841 | 7.88 | 28.38 | 799,975 | 10,950,168 | |
| 2016-12-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,051 | 106,184 | 1.00 | ||||
| 2016-12-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 17,204 | 139,513 | 14.07 | ||||
| 2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -20,077 | 674,169 | -2.89 | 0.45 | -9,035 | 303,376 | |
| 2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -21,923 | 736,170 | -2.89 | 0.45 | -9,865 | 331,276 | |
| 2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -40,450 | 694,246 | -5.51 | 0.47 | -19,012 | 326,296 | |
| 2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -44,170 | 758,093 | -5.51 | 0.47 | -20,760 | 356,304 | |
| 2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -24,092 | 734,696 | -3.18 | 0.51 | -12,287 | 374,695 | |
| 2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -26,308 | 802,263 | -3.18 | 0.51 | -13,417 | 409,154 | |
| 2016-12-14 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34,606 | 213,805 | 19.31 | 28.90 | 1,000,113 | 6,178,964 | |
| 2016-12-01 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,040 | 105,133 | 1.00 | ||||
| 2016-12-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6,854 | 5,288,980 | 0.13 | 29.18 | 200,000 | 154,332,436 | |
| 2016-12-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 24,494 | 357,653 | 7.35 | 32.66 | 799,974 | 11,680,947 | |
| 2016-11-16 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Series B Preferred Stock |
C - Conversion | -2,142,857 | 0 | -100.00 | ||||
| 2016-11-16 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
C - Conversion | 428,571 | 828,571 | 107.14 | ||||
| 2016-11-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7,662 | 5,282,126 | 0.15 | 26.10 | 199,978 | 137,863,489 | |
| 2016-11-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 29,985 | 333,159 | 9.89 | 26.68 | 800,000 | 8,888,682 | |
| 2016-11-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,030 | 104,093 | 1.00 | ||||
| 2016-10-04 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,020 | 103,063 | 1.00 | ||||
| 2016-10-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7,137 | 5,274,464 | 0.14 | 28.02 | 199,979 | 147,790,481 | |
| 2016-10-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 29,154 | 303,174 | 10.64 | 27.44 | 799,986 | 8,319,095 | |
| 2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Convertible Promissory Note |
P - Purchase | 2,604,345 | ||||||
| 2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 2,604,345 | 2,604,345 | |||||
| 2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 3,913,979 | 3,913,979 | |||||
| 2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 7,325 | 7,325 | |||||
| 2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 236,851 | 236,851 | |||||
| 2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Convertible Promissory Note |
P - Purchase | |||||||
| 2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Convertible Promissory Note |
P - Purchase | |||||||
| 2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Convertible Promissory Note |
P - Purchase | |||||||
| 2016-09-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7,923 | 5,267,327 | 0.15 | 25.24 | 199,977 | 132,947,333 | |
| 2016-09-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 27,586 | 274,020 | 11.19 | 29.00 | 799,994 | 7,946,580 | |
| 2016-09-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,010 | 102,043 | 1.00 | ||||
| 2016-08-18 |
|
4 | XON |
INTREXON CORP
Option to Purchase Common Stock |
X - Other | -2,957 | 0 | -100.00 | ||||
| 2016-08-18 |
|
4 | XON |
INTREXON CORP
Option to Purchase Common Stock |
X - Other | -8,871 | 0 | -100.00 | ||||
| 2016-08-18 |
|
4 | XON |
INTREXON CORP
Common Stock |
X - Other | 2,957 | 5,259,404 | 0.06 | 3.18 | 9,403 | 16,724,905 | |
| 2016-08-18 |
|
4 | XON |
INTREXON CORP
Common Stock |
X - Other | 8,871 | 5,256,447 | 0.17 | 2.65 | 23,508 | 13,929,585 | |
| 2016-08-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7,895 | 5,247,576 | 0.15 | 25.33 | 199,980 | 132,921,100 | |
| 2016-08-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 32,586 | 246,434 | 15.24 | 24.55 | 799,986 | 6,049,955 | |
| 2016-08-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1,033 | 101,033 | 1.03 | ||||
| 2016-07-06 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
P - Purchase | 100,000 | 100,000 | |||||
| 2016-07-05 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
P - Purchase | 2,261,419 | 14,481,089 | 18.51 | 0.52 | 1,166,666 | 7,470,794 | |
| 2016-07-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 8,126 | 5,239,681 | 0.16 | 24.61 | 199,981 | 128,948,549 | |
| 2016-07-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 31,372 | 213,848 | 17.19 | 25.50 | 799,986 | 5,453,124 | |
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 19,711 | 19,711 | |||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 59,133 | 59,133 | |||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 118,266 | 118,266 | |||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 3,952 | 135,033 | 3.01 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 24,583 | 843,044 | 3.00 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 2,016 | 75,684 | 2.74 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 20,976 | 850,355 | 2.53 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 20,976 | 850,355 | 2.53 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8,977 | 158,885,269 | 0.01 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8,977 | 114,181 | 8.53 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8,977 | 114,181 | 8.53 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 335 | 1,403 | 31.37 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 73,763 | 311,287 | 31.05 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 334,737 | 5,231,555 | 6.84 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | -1,196,077 | 0 | -100.00 | ||||
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6,506 | 4,896,818 | 0.13 | 30.74 | 199,994 | 150,528,185 | |
| 2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 32,854 | 182,476 | 21.96 | 24.35 | 799,995 | 4,443,291 | |
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 21,858 | 21,858 | |||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 65,572 | 65,572 | |||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 131,144 | 131,144 | |||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 4,382 | 46,701 | 10.35 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 27,260 | 290,460 | 10.36 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 2,235 | 2,235 | |||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 23,259 | 354,653 | 7.02 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 23,259 | 354,653 | 7.02 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 9,954 | 41,836,607 | 0.02 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 9,954 | 302,954 | 3.40 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 9,954 | 302,954 | 3.40 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 372 | 11,317 | 3.40 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 371,186 | 3,056,601 | 13.82 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 81,795 | 216,795 | 60.59 | ||||
| 2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | -1,326,320 | 0 | -100.00 | ||||
| 2016-05-16 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 41,830 | 6,649,997 | 0.63 | 23.92 | 1,000,574 | 159,067,928 | |
| 2016-05-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 20,202 | 3,538,253 | 0.57 | ||||
| 2016-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 21,074 | 149,622 | 16.39 | 37.96 | 799,969 | 5,679,651 | |
| 2016-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7,482 | 4,890,312 | 0.15 | 26.73 | 199,994 | 130,718,040 | |
| 2016-04-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 23,398 | 128,548 | 22.25 | 34.19 | 799,978 | 4,395,056 | |
| 2016-04-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 5,901 | 4,882,830 | 0.12 | 33.89 | 199,985 | 165,479,109 | |
| 2016-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 26,963 | 105,150 | 34.49 | 29.67 | 799,992 | 3,119,800 | |
| 2016-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6,462 | 4,876,929 | 0.13 | 30.95 | 199,999 | 150,940,953 | |
| 2016-02-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 29,509 | 78,187 | 60.62 | 27.11 | 799,989 | 2,119,650 | |
| 2016-02-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6,863 | 4,870,467 | 0.14 | 29.14 | 199,988 | 141,925,408 | |
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 32,205 | 32,205 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 32,205 | 32,205 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A-1 Convertible Preferred Stock |
P - Purchase | 42,941 | 42,941 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A-1 Convertible Preferred Stock |
P - Purchase | 42,941 | 42,941 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 32,205 | 32,205 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A-1 Convertible Preferred Stock |
P - Purchase | 42,941 | 42,941 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 64,411 | 64,411 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A-1 Convertible Preferred Stock |
P - Purchase | 85,882 | 85,882 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
C - Conversion | -577,319 | 0 | -100.00 | ||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
C - Conversion | -577,319 | 0 | -100.00 | ||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
C - Conversion | -288,659 | 0 | -100.00 | ||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A Convertible Preferred Stock |
C - Conversion | -517,241 | 0 | -100.00 | ||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A Convertible Preferred Stock |
C - Conversion | -1,034,482 | 0 | -100.00 | ||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A Convertible Preferred Stock |
C - Conversion | -1,034,482 | 0 | -100.00 | ||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 317,294 | 894,613 | 54.96 | 1.00 | 317,294 | 894,613 | |
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 577,319 | 577,319 | |||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 894,965 | 1,510,135 | 145.48 | 1.00 | 894,965 | 1,510,135 | |
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 461,072 | 615,170 | 299.21 | ||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 1,472,636 | 2,125,654 | 225.51 | 1.00 | 1,472,636 | 2,125,654 | |
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 344,822 | 653,018 | 111.88 | ||||
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 1,789,930 | 3,020,267 | 145.48 | 1.00 | 1,789,930 | 3,020,267 | |
| 2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 922,141 | 1,230,337 | 299.21 | ||||
| 2016-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 26,041 | 48,678 | 115.04 | 30.72 | 799,980 | 1,495,388 | |
| 2016-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6,633 | 4,863,604 | 0.14 | 30.15 | 199,985 | 146,637,661 | |
| 2016-01-04 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 26,661 | 122,309 | 27.87 | ||||
| 2015-12-14 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34,100 | 6,608,167 | 0.52 | 29.83 | 1,017,203 | 197,121,622 | |
| 2015-12-14 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 90,375 | 6,574,067 | 1.39 | 29.86 | 2,698,598 | 196,301,641 | |
| 2015-12-07 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 237,525 | 6,483,692 | 3.80 | 30.69 | 7,289,642 | 198,984,507 | |
| 2015-12-03 |
|
4 | OGEN |
ORAGENICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
| 2015-12-03 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
C - Conversion | 3,381,004 | 12,219,670 | 38.25 | 1.50 | 5,071,506 | 18,329,505 | |
| 2015-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 22,637 | 22,637 | 35.34 | 799,992 | 799,992 | ||
| 2015-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
G - Gift | -200 | 4,856,971 | 0.00 | ||||
| 2015-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 5,508 | 4,857,171 | 0.11 | 36.31 | 199,995 | 176,363,879 | |
| 2015-09-04 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
P - Purchase | 937,500 | 9,613,268 | 10.81 | 3.20 | 3,000,000 | 30,762,458 | |
| 2015-07-27 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 375,868 | 6,400,783 | 6.24 | 5.80 | 2,180,034 | 37,124,541 | |
| 2015-07-27 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 18,003 | 18,003 | 5.80 | 104,417 | 104,417 | ||
| 2015-07-27 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 582,116 | 582,116 | 5.80 | 3,376,273 | 3,376,273 | ||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 86,556 | 86,556 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 173,111 | 173,111 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 58,746 | 58,746 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 176,238 | 176,238 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 352,477 | 352,477 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 111,339 | 111,339 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 222,680 | 222,680 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 395,791 | 395,791 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 889,513 | 889,513 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 1,013,146 | 2,359,608 | 75.25 | ||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 61,262 | 61,262 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 138,975 | 138,975 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 154,181 | 154,181 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 29,066 | 29,066 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 34,318 | 34,318 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 358,386 | 358,386 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 337,333 | 337,333 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 9,537 | 9,537 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 53,245 | 53,245 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 240 | 240 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 40,954 | 40,954 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 23,504 | 23,504 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 23,349 | 23,349 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 3,479,006 | 3,479,006 | |||||
| 2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | -17,830,305 | 0 | -100.00 | ||||
| 2015-05-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 13,175 | 3,518,051 | 0.38 | ||||
| 2015-03-18 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Warrant to Purchase Common Stock |
P - Purchase | 3,484,848 | 3,484,848 | |||||
| 2015-03-18 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
P - Purchase | 13,939,392 | 37,939,392 | 58.08 | 0.16 | 2,300,000 | 6,260,000 | |
| 2015-02-10 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
P - Purchase | 1,440,000 | 17,830,305 | 8.79 | 8.75 | 12,600,000 | 156,015,169 | |
| 2015-01-27 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 55,556 | 5,483,957 | 1.02 | 27.00 | 1,500,012 | 148,066,839 | |
| 2015-01-27 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 500,000 | 6,246,167 | 8.70 | 27.00 | 13,500,000 | 168,646,509 | |
| 2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 58,800 | 58,800 | |||||
| 2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 58,800 | 58,800 | |||||
| 2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 1,068 | 1,068 | |||||
| 2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 28,593 | 105,204 | 37.32 | ||||
| 2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 28,593 | 55,784,792 | 0.05 | ||||
| 2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 28,593 | 55,783,837 | 0.05 | ||||
| 2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 139,811 | 4,851,663 | 2.97 | ||||
| 2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | -1,679,578 | 0 | -100.00 | ||||
| 2015-01-05 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 16,707 | 95,648 | 21.16 | ||||
| 2014-12-10 | 3 | HSGX |
HISTOGENICS CORP
Common Stock |
5,381,140 | ||||||||
| 2014-12-10 | 3 | HSGX |
HISTOGENICS CORP
Common Stock |
5,381,140 | ||||||||
| 2014-12-10 | 3 | HSGX |
HISTOGENICS CORP
Common Stock |
5,381,140 | ||||||||
| 2014-06-06 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 400,000 | 9,619,512 | 4.34 | 2.90 | 1,160,000 | 27,896,585 | |
| 2014-05-29 |
|
4/A | XON |
INTREXON CORP
Common Stock |
P - Purchase | 32,019 | 829,379 | 4.02 | 15.63 | 500,457 | 12,963,194 | |
| 2014-05-29 |
|
4/A | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18,066 | 797,360 | 2.32 | 15.89 | 287,069 | 12,670,050 | |
| 2014-05-29 |
|
4/A | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2,160 | 129,794 | 1.69 | 14.24 | 30,758 | 1,848,267 | |
| 2014-05-29 |
|
4/A | XON |
INTREXON CORP
Common Stock |
P - Purchase | 15,088 | 779,294 | 1.97 | 13.42 | 202,481 | 10,458,125 | |
| 2014-05-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 24,876 | 3,504,876 | 0.71 | ||||
| 2014-05-13 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 32,019 | 829,379 | 4.02 | 15.63 | 500,457 | 12,963,194 | |
| 2014-05-13 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18,066 | 797,360 | 2.32 | 15.89 | 287,069 | 12,670,050 | |
| 2014-05-13 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 15,088 | 779,294 | 1.97 | 13.42 | 202,481 | 10,458,125 | |
| 2014-03-31 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 243,001 | 243,001 | 25.72 | 6,249,986 | 6,249,986 | ||
| 2014-03-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
P - Purchase | 288,659 | 288,659 | 4.85 | 1,399,996 | 1,399,996 | ||
| 2014-03-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
P - Purchase | 577,319 | 577,319 | 4.85 | 2,799,997 | 2,799,997 | ||
| 2014-03-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
P - Purchase | 577,319 | 577,319 | 4.85 | 2,799,997 | 2,799,997 | ||
| 2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
64,000,000 | ||||||||
| 2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
68,000,000 | ||||||||
| 2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
64,000,000 | ||||||||
| 2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
68,000,000 | ||||||||
| 2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
64,000,000 | ||||||||
| 2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
68,000,000 | ||||||||
| 2014-01-28 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 1,024,590 | 6,024,915 | 20.49 | 4.88 | 4,999,999 | 29,401,585 | |
| 2014-01-03 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 18,818 | 78,941 | 31.30 | ||||
| 2013-12-26 |
|
4 | OGEN |
ORAGENICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
| 2013-12-26 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
C - Conversion | 698,241 | 8,838,666 | 8.58 | 2.82 | 1,969,040 | 24,925,038 | |
| 2013-12-19 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
P - Purchase | 2,000,000 | 8,675,768 | 29.96 | 1.00 | 2,000,000 | 8,675,768 | |
| 2013-12-19 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
P - Purchase | 500,000 | 3,625,000 | 16.00 | 1.00 | 500,000 | 3,625,000 | |
| 2013-11-22 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
P - Purchase | 1,099,490 | 8,140,425 | 15.62 | 2.50 | 2,748,725 | 20,351,062 | |
| 2013-11-22 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
P - Purchase | 143,000 | 1,000,555 | 16.68 | 2.50 | 357,500 | 2,501,388 | |
| 2013-10-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
P - Purchase | 2,857,143 | 16,390,305 | 21.11 | 3.50 | 10,000,000 | 57,366,068 | |
| 2013-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
X - Other | -10,000 | 0 | -100.00 | ||||
| 2013-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
X - Other | 10,000 | 3,480,000 | 0.29 | 4.94 | 49,400 | 17,191,200 | |
| 2013-10-03 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 2,439,024 | 5,000,325 | 95.23 | 4.10 | 9,999,998 | 20,501,332 | |
| 2013-10-03 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 1,219,512 | 9,219,512 | 15.24 | 4.10 | 4,999,999 | 37,799,999 | |
| 2013-10-02 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
P - Purchase | 2,648,510 | 7,040,935 | 60.30 | 3.00 | 7,945,530 | 21,122,805 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -50,904 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -38,510 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -33,016 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -86,200 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -875,800 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -452,537 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -141,588 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -64,300 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -394,995 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -448,185 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -362,286 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -77,419 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -49,980 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -42,794 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 3,709 | 73,668 | 5.30 | 16.00 | 59,344 | 1,178,688 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 69,959 | 69,959 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 51,213 | 940,426 | 5.76 | 16.00 | 819,408 | 15,046,816 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 889,213 | 889,213 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 38,628 | 764,206 | 5.32 | 16.00 | 618,048 | 12,227,296 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 725,578 | 725,578 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 5,185 | 102,437 | 5.33 | 16.00 | 82,960 | 1,638,992 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 97,252 | 97,252 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -47,055 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -40,968 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -39,492 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -109,200 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -1,108,800 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -128,508 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -64,300 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -361,815 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -422,375 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -312,890 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -75,839 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -49,980 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -42,794 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 3,747 | 76,611 | 5.14 | 16.00 | 59,952 | 1,225,776 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 72,864 | 72,864 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 49,028 | 818,461 | 6.37 | 16.00 | 784,448 | 13,095,376 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 769,433 | 769,433 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 35,942 | 699,586 | 5.42 | 16.00 | 575,072 | 11,193,376 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 663,644 | 663,644 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 5,133 | 101,482 | 5.33 | 16.00 | 82,128 | 1,623,712 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 96,349 | 96,349 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -17,555 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -178,254 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -19,808 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -295,858 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series B Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series B Convertible Preferred Stock |
C - Conversion | -694,000 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series B-1 Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series B-1 Convertible Preferred Stock |
C - Conversion | -1,212,360 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -909,272 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -1,977,666 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -295,514 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -1,917,360 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -299,532 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -958,680 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -149,766 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 7,873 | 131,081 | 6.39 | 16.00 | 125,968 | 2,097,296 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 123,208 | 123,208 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 10,138 | 179,199 | 6.00 | 16.00 | 162,208 | 2,867,184 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 169,061 | 169,061 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 70,646 | 1,679,578 | 4.39 | 16.00 | 1,130,336 | 26,873,248 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1,608,932 | 1,608,932 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 65,983 | 1,196,077 | 5.84 | 16.00 | 1,055,728 | 19,137,232 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1,130,094 | 1,130,094 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 9,859 | 178,724 | 5.84 | 16.00 | 157,744 | 2,859,584 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 168,865 | 168,865 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 89,853 | 1,356,648 | 7.09 | 16.00 | 1,437,648 | 21,706,368 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1,266,795 | 1,266,795 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 44,926 | 678,323 | 7.09 | 16.00 | 718,816 | 10,853,168 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 633,397 | 633,397 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -1,917,360 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -299,532 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-1 Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-1 Convertible Preferred Stock |
C - Conversion | -15,934,528 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-2 Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-2 Convertible Preferred Stock |
C - Conversion | -18,617,020 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-3 Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-3 Convertible Preferred Stock |
C - Conversion | -13,271,277 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -4,437,870 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -3,047,620 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -656,716 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -4,053,784 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -2,976,756 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -190,477 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -4,620,071 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -3,054,236 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -3,054,236 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -5,023,770 | 0 | -100.00 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 89,853 | 1,356,648 | 7.09 | 16.00 | 1,437,648 | 21,706,368 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1,266,795 | 1,266,795 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1,360,445 | 22,636,052 | 6.39 | 16.00 | 21,767,120 | 362,176,832 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 19,743,741 | 21,275,607 | 1,288.87 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 636,205 | 13,340,645 | 5.01 | 16.00 | 10,179,280 | 213,450,320 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 11,861,008 | 12,704,440 | 1,406.28 | ||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 319,135 | 4,711,852 | 7.27 | 16.00 | 5,106,160 | 75,389,632 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 4,392,717 | 4,392,717 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12,500 | 127,634 | 10.86 | 16.00 | 200,000 | 2,042,144 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 6,290 | 115,134 | 5.78 | 16.00 | 100,640 | 1,842,144 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 108,844 | 108,844 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 937,500 | 5,428,401 | 20.88 | 16.00 | 15,000,000 | 86,854,416 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 937,500 | 5,428,401 | 20.88 | 16.00 | 15,000,000 | 86,854,416 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 105,584 | 4,490,901 | 2.41 | 16.00 | 1,689,344 | 71,854,416 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 4,385,317 | 4,385,317 | |||||
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 192,665 | 4,808,667 | 4.17 | 16.00 | 3,082,640 | 76,938,672 | |
| 2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 4,616,002 | 4,616,002 | |||||
| 2013-08-07 | 3 | XON |
INTREXON CORP
Common Stock |
1,531,866 | ||||||||
| 2013-08-07 | 3 | XON |
INTREXON CORP
Common Stock |
843,432 | ||||||||
| 2013-07-30 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 1,243,781 | 2,561,301 | 94.40 | 6.03 | 7,499,999 | 15,444,645 | |
| 2013-06-26 | 3 | SNGX |
SOLIGENIX, INC.
Common Stock |
3,333,333 | ||||||||
| 2013-06-26 | 3 | SNGX |
SOLIGENIX, INC.
Common Stock |
1,034,483 | ||||||||
| 2013-05-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 20,000 | 3,470,000 | 0.58 | ||||
| 2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 600,000 | 600,000 | |||||
| 2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 1,200,000 | 1,200,000 | |||||
| 2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 1,200,000 | 1,200,000 | |||||
| 2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 1,200,000 | 1,849,181 | 184.85 | ||||
| 2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 2,400,000 | 3,698,361 | 184.85 | ||||
| 2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 2,400,000 | 3,698,361 | 184.85 | ||||
| 2013-01-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 17,546 | 60,123 | 41.21 | ||||
| 2012-11-09 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
P - Purchase | 3,636,926 | 13,533,162 | 36.75 | ||||
| 2012-10-31 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
P - Purchase | 3,125,000 | 3,125,000 | 1.60 | 5,000,000 | 5,000,000 | ||
| 2012-10-19 | 3 | SYN |
Synthetic Biologics, Inc.
Common Stock |
6,675,768 | ||||||||
| 2012-10-15 | 3 | FCSC |
Fibrocell Science, Inc.
Common Stock |
200,000,000 | ||||||||
| 2012-10-15 | 3 | FCSC |
Fibrocell Science, Inc.
Common Stock |
32,938,000 | ||||||||
| 2012-08-02 |
|
4 | ORNI |
ORAGENICS INC
Common Stock |
P - Purchase | 857,555 | 857,555 | 1.50 | 1,286,332 | 1,286,332 | ||
| 2012-06-12 | 3 | ORNI |
ORAGENICS INC
Common Stock |
4,392,425 | ||||||||
| 2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 2,731 | 331,394 | 0.83 | 7.48 | 20,428 | 2,478,827 | |
| 2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 2,732 | 331,395 | 0.83 | 7.48 | 20,435 | 2,478,835 | |
| 2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 44,823 | 328,663 | 15.79 | 7.37 | 330,346 | 2,422,246 | |
| 2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 44,823 | 328,663 | 15.79 | 7.37 | 330,346 | 2,422,246 | |
| 2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 49,540 | 283,840 | 21.14 | 7.39 | 366,101 | 2,097,578 | |
| 2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 49,540 | 283,840 | 21.14 | 7.39 | 366,101 | 2,097,578 | |
| 2012-05-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 299,007 | 3,977,445 | 8.13 | 7.50 | 2,242,552 | 29,830,838 | |
| 2012-05-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 344,910 | 3,678,438 | 10.35 | 7.44 | 2,566,130 | 27,367,579 | |
| 2012-05-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 427,581 | 3,333,528 | 14.71 | 7.35 | 3,142,720 | 24,501,431 | |
| 2012-05-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 20,000 | 3,450,000 | 0.58 | ||||
| 2012-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 185,000 | 234,300 | 375.25 | 10.61 | 1,962,850 | 2,485,923 | |
| 2012-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 185,000 | 234,300 | 375.25 | 10.61 | 1,962,850 | 2,485,923 | |
| 2012-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 990,000 | 2,905,947 | 51.67 | 10.61 | 10,503,900 | 30,832,098 | |
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
C - Conversion | 300,000 | 300,000 | |||||
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
C - Conversion | 600,000 | 600,000 | |||||
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
C - Conversion | 600,000 | 600,000 | |||||
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 600,000 | 649,181 | 1,219.98 | ||||
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 1,200,000 | 1,298,361 | 1,220.00 | ||||
| 2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 1,200,000 | 1,298,361 | 1,220.00 | ||||
| 2012-01-23 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
P - Purchase | 1,923,075 | 9,896,236 | 24.12 | 5.20 | 9,999,990 | 51,460,427 | |
| 2012-01-03 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 17,577 | 42,577 | 70.31 |
